1.Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the american society for radiation oncology (astro). Int. J. Radiat. Oncol. Biol. Phys. 2009; 74:987–1001.
2.Lindeman R, Tobin J, Shock N. Longitudinal studies on the rate of decline in renal function with age. Journal of the American Geriatrics Society 1985; 33:278–285.
3.Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Current Opinion in Hematology 2005; 12:123–128.
4.LeBlanc TW, McNeil MJ, Kamal AH, Currow DC, Abernethy AP. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. The Lancet Oncology 2015; 16:e333-e341.
5.Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: An update on siog recommendationsdagger. Ann Oncol 2015; 26:288–300.
6.Mohile SG, Dale W, Somerfield MR, Hurria A. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: Asco guideline for geriatric oncology summary. Journal of Oncology Practice 2018; 14:442-+.
7.Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz J-P, Lichtman S, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on cga of the international society of geriatric oncology (siog). Critical reviews in oncology/hematology 2005; 55:241–52.
8.VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, et al. Nccn guidelines insights: Older adult oncology, version 2.2016. J Natl Compr Canc Netw 2016; 14:1357–1370.
9.Mohile SG, Hurria A, Cohen HJ, Rowland JH, Leach CR, Arora NK, et al. Improving the quality of survivorship for older adults with cancer. Cancer 2016; 122:2459–568.
10.Basta YL, Bolle S, Fockens P, Tytgat K. The value of multidisciplinary team meetings for patients with gastrointestinal malignancies: A systematic review. Ann Surg Oncol 2017; 24:2669–2678.
11.Munro A, Brown M, Niblock P, Steele R, Carey F. Do multidisciplinary team (mdt) processes influence survival in patients with colorectal cancer? A population-based experience. BMC Cancer 2015; 15:686.
12.Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev 2016; 42:56–72.
13.American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60:616–31.
14.Chisolm TH, Johnson CE, Danhauer JL, Portz LJP, Abrams HB, Lesner S, et al. A systematic review of health-related quality of life and hearing aids: Final report of the american academy of audiology task force on the health-related quality of life benefits of amplification in adults. J Am Acad Audiol 2007; 18:151–183.
15.Farcet A, de Decker L, Pauly V, Rousseau F, Bergman H, Molines C, et al. Frailty markers and treatment decisions in patients seen in oncogeriatric clinics: Results from the asro pilot study. Plos One 2016; 11:
16.Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc JF, Ceccaldi J, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 2013; 31:3877–82.
17.Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 1983; 140:734–9.
18.Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, moca: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695–9.
19.Karuturi M, Wong ML, Hsu T, Kimmick GG, Lichtman SM, Holmes HM, et al. Understanding cognition in older patients with cancer. J Geriatr Oncol 2016; 7:258–69.
20.Buatois S, Miljkovic D, Manckoundia P, Gueguen R, Miget P, Vancon G, et al. Five times sit to stand test is a predictor of recurrent falls in healthy community-living subjects aged 65 and older. J Am Geriatr Soc 2008; 56:1575–7.
21.Wrisley DM, Kumar NA. Functional gait assessment: Concurrent, discriminative, and predictive validity in community-dwelling older adults. Physical therapy 2010; 90:761–73.
22.Podsiadlo D, Richardson S. The timed “Up & go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39:142–8.
23.Soubeyran P, Brouste V, Bellera C, Rainfray M. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer and the importance of geriatric assessment reply. Journal of Clinical Oncology 2012; 30:4443–4445.
24.Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R. Haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide and peripheral blood stem cell grafts in older adults with acute myeloid leukemia or myelodysplastic syndrome. Biol Blood Marrow Transplant 2017; 23:1736–1743.
25.McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 2010; 28:1878–87.
26.Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica 2014; 99:1373–9.
27.Muffly LS, Boulukos M, Swanson K, Kocherginsky M, Cerro PD, Schroeder L, et al. Pilot study of comprehensive geriatric assessment (cga) in allogeneic transplant: Cga captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant 2013; 19:429–34.
28.Rosko AE, Huang Y, Benson DM, Efebera YA, Hofmeister C, Jaglowski S, et al. Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant. J Geriatr Oncol 2018;
29.Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne 2005; 173:489–95.
30.Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol 2016; 34:2366–71.
31.CIBMTR. Survival calculator. 2016.
32.Girones R, Torregrosa D, Gomez-Codina J, Maestu I, Tenias JM, Rosell R. Prognostic impact of comorbidity in elderly lung cancer patients: Use and comparison of two scores. Lung Cancer 2011; 72:108–13.
33.Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer. New England Journal of Medicine 2018; 378:2078–2092.
34.Kah Poh Loh ES-P-d-C, Tina Hsu, Nienke A. de Glas, Nicol’o Matteo Luca Battisti, Capucine Baldini, Manuel Rodrigues, Stuart M. Lichtman, and Hans Wildiers. What every oncologist should know about geriatric assessment for older patients with cancer: Young international society of
geriatric oncology position paper. Journal of Oncology Practice 2018; 14:85–94.
35.Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. Journal of Clinical Oncology 2011; 29:3457–3465.
36.Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: The chemotherapy risk assessment scale for high-age patients (crash) score. Cancer 2012; 118:3377–3386.
37.Feng MA, McMillan DT, Crowell K, Muss H, Nielsen ME, Smith AB. Geriatric assessment in surgical oncology: A systematic review. J Surg Res 2015; 193:265–72.
38.Benjamin AJ, Buschmann MM, Zhang SQ, Wroblewski K, Kindler HL, Roggin KK, et al. The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer. J Geriatr Oncol 2018; 9:367–372.
39.American Cancer Society. Breast cancer facts & figures, 2015–2016. 2015;
40.Christman K, Muss HB, Case LD, Stanley V. Chemotherapy of metastatic breast cancer in the elderly: The piedmont oncology association experience. JAMA 1992; 268:57–62.
41.Hurria A, Soto-Perez-de-Celis E, Blanchard S, al. e. A phase ii trial of older adults with metastatic breast cancer receving nap-paclitaxel: Melding the fields of geriatrics and oncology. Clinical Breast Cancer 2019; 19:18–96.
42.McConnell ES, Lekan D, Bunn M, Egerton E, Corazzini KN, Hendrix CD, et al. Teaching evidence-based nursing practice in geriatric care settings: The geriatric nursing innovations through education institute. Journal of gerontological nursing 2009; 35:26–33; quiz 34–5.
43.Overcash J. Integrating geriatrics into oncology ambulatory care clinics. Clinical journal of oncology nursing 2015; 19:E80–6.
44.Gilje F, Lacey L, Moore C. Gerontology and geriatric issues and trends in u.S. Nursing programs: A national survey. Journal of professional nursing: official journal of the American Association of Colleges of Nursing 2007; 23:21–9.
45.Cremolini C, Del Re M, Antoniotti C, Lonardi S, Bergamo F, Loupakis F, et al. Dpyd and ugt1a1 genotyping to predict adverse events during first-line folfiri or folfoxiri plus bevacizumab in metastatic colorectal cancer. Oncotarget 2018; 9:7859–7866.
46.Bellizzi KM, Mustian KM, Palesh OG, Diefenbach M. Cancer survivorship and aging: Moving the science forward. Cancer 2008; 113:3530–9.
47.Burg MA, Adorno G, Lopez ED, Loerzel V, Stein K, Wallace C, et al. Current unmet needs of cancer survivors: Analysis of open-ended responses to the american cancer society study of cancer survivors ii. Cancer 2015; 121:623–30.
48.Krok-Schoen JL, Naughton MJ, Bernardo BM, Young GS, Paskett ED. Fear of recurrence among older breast, ovarian, endometrial, and colorectal cancer survivors: Findings from the whi lilac study. Psychooncology 2018;
49.Faul LA, Luta G, Sheppard V, Isaacs C, Cohen HJ, Muss HB, et al. Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: Calgb/alliance 369901. Journal of cancer survivorship: research and practice 2014; 8:627–37.
50.ASoC O. American society of clinical oncology clinical practice survivorship guidelines and adaptations. 2013;
51.O’Caoimh R, Cornally N, O’Sullivan R, Hally R, Weathers E, Lavan AH, et al. Advance care planning within survivorship care plans for older cancer survivors: A systematic review. Maturitas 2017; 105:52–57.
52.Korc-Grodzicki B, Tew W, Hurria A, Yulico H, Lichtman S, Hamlin P, et al. Development of a geriatric service in a cancer center: Lessons learned. Journal of oncology practice 2017; 13:107–112.
53.Chapman AE, Swartz K, Schoppe J, Arenson C. Development of a comprehensive multidisciplinary geriatric oncology center, the thomas jefferson university experience. J Geriatr Oncol 2014; 5:164–70.
54.McNeil C. Geriatric oncology clinics on the rise. Journal of the National Cancer Institute 2013; 105:585–6.
55.Lynch MP, Marcone D, Kagan SH. Developing a multidisciplinary geriatric oncology program in a community cancer center. Clinical journal of oncology nursing 2007; 11:929–33.
56.Lusardi MM, Pellecchia GL, Schulman M. Functional performance in community living older adults. Journal of Geriatric Physical Therapy 2003; 26:14–22.